Is BMY stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-22, Bristol-Myers Squibb Company (NYSE: BMY) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 54/100 at a spot price of $58.34 (-2.06% 1D, market cap $119.24B). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 9/20, SEC Balance-Sheet Forensics 12/20, FRED Macro Regime Fit 5/20, and Executive Insider Alignment 17/20. Across 1015 tracked Health Care issuers, BMY ranks #183 in composite RQD confidence.